Paul Jaminet

Paul Jaminet

Company: Angiex

Job title: CEO


Improving your Therapeutic Index Using Novel Nuclear Delivered ADCs 2:45 pm

Discover how by understanding target biology, and careful tailoring of ADC design is the key to achieving high therapeutic index Learn the possibilities surrounding the use of AGX101 to increase the therapeutic index up to 10-fold Evaluate the use of nuclear-delivered antibody-drug conjugates, which are now in the clinic, to reduce toxicityRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.